Skip to main content
Equibles

HighTower Advisors, LLC

Position in DYAI — Dyadic International Inc

CIK 1462245 CHICAGO, IL
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$71,522
+$6,358 QoQ
Shares Held
79,469
0.0% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 39 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. DYAI ranks #83 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 870,551 $82,484,707
2 REGN
Regeneron Pharmaceuticals, Inc.
 64,650 $40,311,861
3 ALNY
Alnylam Pharmaceuticals, Inc.
 105,045 $31,621,696
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,020 $24,349,704
5 RPRX
Royalty Pharma plc
 285,630 $16,015,274
6 EXEL
Exelixis, Inc.
 291,162 $15,842,124
7 AXSM
Axsome Therapeutics, Inc.
 56,313 $13,783,733
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 140,394 $11,443,514

All Filings in DYAI

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $71,522 79,469
2026-03-31 $65,164 79,469
2025-12-31 $74,700 79,469
2025-09-30 $93,773 79,469
2025-06-30 $78,674 79,469
2025-03-31 $107,418 79,569
2024-12-31 $139,245 79,569
2024-09-30 $82,751 79,569
2024-06-30 $117,318 79,269
2024-03-31 $129,122 77,319